- Home
- BCML vs LUNG Comparison
BCML vs LUNG Comparison
Compare BCML & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCML
- LUNG
- Stock Information
- Founded
- BCML 2004
- LUNG 1995
- Country
- BCML United States
- LUNG United States
- Employees
- BCML N/A
- LUNG N/A
- Industry
- BCML Major Banks
- LUNG Industrial Specialties
- Sector
- BCML Finance
- LUNG Health Care
- Exchange
- BCML Nasdaq
- LUNG Nasdaq
- Market Cap
- BCML 294.2M
- LUNG 124.0M
- IPO Year
- BCML N/A
- LUNG 2020
- Fundamental
- Price
- BCML $28.89
- LUNG $2.78
- Analyst Decision
- BCML
- LUNG Buy
- Analyst Count
- BCML 0
- LUNG 6
- Target Price
- BCML N/A
- LUNG $11.53
- AVG Volume (30 Days)
- BCML 31.9K
- LUNG 311.3K
- Earning Date
- BCML 07-17-2025
- LUNG 07-30-2025
- Dividend Yield
- BCML 2.77%
- LUNG N/A
- EPS Growth
- BCML N/A
- LUNG N/A
- EPS
- BCML 2.10
- LUNG N/A
- Revenue
- BCML $95,714,000.00
- LUNG $87,473,000.00
- Revenue This Year
- BCML $1.20
- LUNG $18.02
- Revenue Next Year
- BCML $6.66
- LUNG $18.17
- P/E Ratio
- BCML $13.76
- LUNG N/A
- Revenue Growth
- BCML N/A
- LUNG 19.84
- 52 Week Low
- BCML $19.26
- LUNG $2.50
- 52 Week High
- BCML $30.13
- LUNG $9.37
- Technical
- Relative Strength Index (RSI)
- BCML 66.53
- LUNG 41.83
- Support Level
- BCML $27.40
- LUNG $2.52
- Resistance Level
- BCML $29.15
- LUNG $2.84
- Average True Range (ATR)
- BCML 0.77
- LUNG 0.16
- MACD
- BCML 0.19
- LUNG 0.04
- Stochastic Oscillator
- BCML 86.65
- LUNG 46.36
About BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.